Opioid-induced hyperalgesia in community-dwelling adults with chronic pain

Pain

Volumn 156, Issue 6, 2015, Pages 1145-1152

  Hooten, W Michael ^a   Lamer, Tim J ^a   Twyner, Channing ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Heat pain perception; Hyperalgesia; Opioid

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGE; ANALGESIA; ARTICLE; BODY MASS; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHRONIC PAIN; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HEAT PAIN THRESHOLD; HEAT SENSATION; HEAT TOLERANCE; HOSPITAL ADMISSION; HUMAN; HYPERALGESIA; KOLMOGOROV SMIRNOV TEST; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT CARE; PAIN ASSESSMENT; PAIN CATASTROPHIZING SCALE; PAIN SEVERITY; PAIN THRESHOLD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX; WORK; CATASTROPHIZING; COMPLICATION; DEMOGRAPHY; DEPRESSION; DRUG EFFECT; PAIN MEASUREMENT; PSYCHOLOGY;

ADULT; ANALGESICS, OPIOID; CATASTROPHIZATION; CHRONIC PAIN; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; RESIDENCE CHARACTERISTICS;

EID: 85013382080     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000170     Document Type: Article

References (59)

1. Angst MS, KoppertW, Pahl I, Clark DJ, SchmelzM. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. PAIN 2003;106:49-57.
2. Backonja MM, Walk D, Edwards RR, Sehgal N, Moeller-Bertram T, Wasan A, Irving G, Argoff C, Wallace M. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain 2009;25:641-7.
3. Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine (Phila Pa 1976) 1995;20: 956-63.
4. Boettger MK, Grossmann D, Bar KJ. Thresholds and perception of cold pain, heat pain, and the thermal grill illusion in patients with major depressive disorder. Psychosom Med 2013;75:281-7.
5. Celerier E, Laulin J, Larcher A, Le Moal M, Simonnet G. Evidence for opiate-activatedNMDA processes masking opiate analgesia in rats. Brain Res 1999;847:18-25.
6. Chen L, Malarick C, Seefeld L, Wang S, Houghton M, Mao J. Altered quantitative sensory testing outcome in subjects with opioid therapy. PAIN 2009;143:65-70.
7. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 2006;7:43-8.
8. Chu LF, D'Arcy N, Brady C, Zamora AK, Young CA, Kim JE, Clemenson AM, Angst MS, Clark JD. Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebocontrolled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. PAIN 2012;153:1583-92.
9. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edn . Hillsdale, NJ: Lawrence Earlbaum Associates, 1988.
10. Cunningham JL, Hayes SE, Townsend CO, Laures HJ, Hooten WM. Associations between spousal or significant other solicitous responses and opioid dose in patients with chronic pain. Pain Med 2012;13: 1034-9.
11. Cunningham JL, Rome JD, Kerkvliet JL, Townsend CO. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs. Pain Med 2009;10: 787-96.
12. DuPen S, DuPen A. Opioid conversion calculator. Poulsbo, WA: Cynergy Group, 2000.
13. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19: 589-601.
14. Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 2000;23:510-7.
15. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995;45:1115-21.
16. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL. A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 1993;43:1508-12.
17. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001;24:307-10.
18. Dyck PJ, Zimmerman I, Gillen DA, Johnson D, Karnes JL, O'Brien PC. Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors. Neurology 1993;43: 1500-8.
19. Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, Gruener G, O'Brien PC. A standard test of heat-pain responses using CASE IV. J Neurol Sci 1996;136:54-63.
20. Dyck PJ, Zimmerman IR, O'Brien PC, Ness A, Caskey PE, Karnes J, Bushek W. Introduction of automated systems to evaluate touchpressure, vibration, and thermal cutaneous sensation in man. Ann Neurol 1978;4:502-10.
21. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009;10:829-39.
22. Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. PAIN 2003;102:243-50.
23. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain 1997;13:163-70.
24. Goodin BR, Glover TL, Sotolongo A, King CD, Sibille KT, Herbert MS, Cruz-Almeida Y, Sanden SH, Staud R, Redden DT, Bradley LA, Fillingim RB. The association of greater dispositional optimism with less endogenous pain facilitation is indirectly transmitted through lower levels of pain catastrophizing. J Pain 2013;14:126-35.
25. Hay JL, White JM, Bochner F, Somogyi AA, Semple TJ, Rounsefell B. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain 2009;10:316-22.
26. Hooten WM, Hartman WR, Black JL III, Laures HJ, Walker DL. Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain. BMC Med Genet 2013; 14:78.
27. Hooten WM, Knight-Brown M, Townsend CO, Laures HJ. Clinical outcomes of multidisciplinary pain rehabilitation among african american compared with caucasian patients with chronic pain. Pain Med 2012;13: 1499-508.
28. Hooten WM, Mantilla CB, Sandroni P, Townsend CO. Associations between heat pain perception and opioid dose among patients with chronic pain undergoing opioid tapering. Pain Med 2010;11:1587-98.
29. Hooten WM, Sandroni P, Mantilla CB, Townsend CO. Associations between heat pain perception and pain severity among patients with chronic pain. Pain Med 2010;11:1554-63.
30. Hooten WM, Townsend CO, Bruce BK, Shi Y, Warner DO. Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation. Pain Med 2009;10:1416-25.
31. Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg 2009;108:308-15.
32. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med 1998;17:1623-34.
33. Joly V, Richebe P, Guignard B, Fletcher D, Maurette P, Sessler DI, Chauvin M. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005;103:147-55.
34. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). PAIN 1985;23:345-56.
35. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schuttler J. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003;99:152-9.
36. Kosek E, Jensen KB, Lonsdorf TB, Schalling M, Ingvar M. Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans. Mol Pain 2009;5:37.
37. Li X, Angst MS, Clark JD. Amurine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 2001;86:56-62.
38. Lindstedt F, Lonsdorf TB, Schalling M, Kosek E, Ingvar M. Perception of thermal pain and the thermal grill illusion is associated with polymorphisms in the serotonin transporter gene. PLoS One 2011;6: e17752.
39. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994;14:2301-12.
40. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23.
41. Palm F, Mossner R, Chen Y, He L, Gerlach M, Bischofs S, Riederer P, Lesch KP, Sommer C. Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter. Eur J Pain 2008;12:790-7.
42. Peltier A, Smith AG, Russell JW, Sheikh K, Bixby B, Howard J, Goldstein J, Song Y, Wang L, Feldman EL, Singleton JR. Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve 2009;39: 529-35.
43. Radloff L. A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
44. Ram KC, Eisenberg E, HaddadM, Pud D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain?new perspective of opioid-induced hyperalgesia. PAIN 2008;139:431-8.
45. Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Botefur IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihofner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. PAIN 2006;123:231-43.
46. Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 2006;10:77-88.
47. Rudy TE. Multiaxial assessment of multidimensional pain inventory: computer program user's manual. Pittsburgh, PA: University of Pittsburgh, 1989.
48. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH. Quantitative sensory testing: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2003; 60:898-904.
49. Sullivan M, Pivik J. The pain castrophizing scale: development and validation. Psychol Assess 1995;7:524-32.
50. Suzan E, Eisenberg E, Treister R, Haddad M, Pud D. A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword? Pain Physician 2013;16:65-76.
51. Townsend CO, Bruce BK, Hooten WM, Rome JD. The role of mental health professionals in multidisciplinary pain rehabilitation programs. J Clin Psychol 2006;62:1433-43.
52. Treister R, Pud D, Ebstein RP, Laiba E, Raz Y, Gershon E, Haddad M, Eisenberg E. Association between polymorphisms in serotonin and dopamine-related genes and endogenous pain modulation. J Pain 2011; 12:875-83.
53. Troster A, Sittl R, Singler B, Schmelz M, Schuttler J, Koppert W.Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology 2006;105:1016-23.
54. Vogel C, Mossner R, Gerlach M, Heinemann T, Murphy DL, Riederer P, Lesch KP, Sommer C. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci 2003;23:708-15.
55. Walk D, Sehgal N, Moeller-BertramT, Edwards RR, Wasan A, WallaceM, Irving G, Argoff C, Backonja MM. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 2009;25: 632-40.
56. Wasner GL, Brock JA. Determinants of thermal pain thresholds in normal subjects. Clin Neurophysiol 2008;119:2389-95.
57. Watkins EA, Wollan PC, Melton LJ III, Yawn BP. A population in pain: report from the Olmsted County health study. Pain Med 2008;9:166-74.
58. Weiss T, Giersch DA, Sauer H, Miltner WH, Bar KJ. Perception to laser heat stimuli in depressed patients is reduced to A delta-and selective C-fiber stimulation. Neurosci Lett 2011;498:89-92.
59. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203-14.